Magnesita has the following transactions related to liabilities in December 2017 and January 2018. Magnesita’s fiscal year end is December 31. Its financial statements are issued in April. 2017 Dec 1 Negotiated a revolving credit agreement with Deutsche Bank that can be renewed annually upon bank approval. The amount available under the line of credit is $20 million at the Bank’s prime rate. Dec 15 Arranged a three-month bank loan of $5 million with Deutsche Bank under the line of credit agreement. Interest at the prime rate of 10% was payable at maturity. Dec 20 Received $200,000 from Nucor Corporation towards the purchase of a $1.2 million order to be delivered on January 15. Dec 24 Sold $750,000 worth of bricks on account to US Steel. The state sales tax is 5% and local sales tax is 2%. Dec 24 The bricks carry a one-year warranty. Based on past experience, Magnesita estimates that warranty costs approximate 1% of sales. Dec 25 Received $12,000 refundable deposit from US Steel relating to containers used to transport bricks. Dec 31 Record any necessary adjusting entry(s) 2018 (Continues on next page) Jan 6 Half of the containers (from Dec 24) were returned. Jan 8 Magnesita incurred warranty costs of $12,000 related to the brick sales from Dec 24. Jan 27 Magnesita determined that the remaining containers (from Dec 24) will not be returned. The original cost of the containers to Magnesita was $4,000.
Journal Entries for the transactions | |||
Date | Description | Debit | Credit |
15-Dec | Cash | $5,000,000 | |
Bank Loan | $5,000,000 | ||
(To record three months bank loan under line of credit arrangement) | |||
20-Dec | Cash | $200,000 | |
Unearned Revenue | $200,000 | ||
(To record advance payment for order to be delivered on Jan 15) | |||
24-Dec | Accounts receivable | $802,500 | |
Sales Revenue | $750,000 | ||
State sales tax payable | $37,500 | ||
Local sales tax payable | $15,000 | ||
(To record sale on account to US steel) | |||
24-Dec | Warranty expenses | $7,500 | |
Warranty liability payable | $7,500 | ||
(To record 1% warranty cost on sales) | |||
25-Dec | Cash | $12,000 | |
Refundable Security Deposit | $12,000 | ||
(To record refundable Security deposit for containers) | |||
Adjusting Journal Entries | |||
Date | Description | Debit | Credit |
31-Dec | Interest expense | $21,917.81 | |
Interest payable | $21,917.81 | ||
(To record interest payable on bank loan for 16 days) | |||
$5000000 x 10% x 16/365 days = $21917.81 | |||
Journal entries for the month of Jan | |||
Date | Description | Debit | Credit |
6-Jan | Refundable Security Deposit | $6,000 | |
Cash | $6,000 | ||
(To record half of the security deposit refunded on retun of half of the containers) | |||
8-Jan | Warranty expense | $4,500 | |
Warranty liability payable | $7,500 | ||
Cash | $12,000 | ||
(To record warranty cost incurred) | |||
27-Jan | Refundable security deposit | $6,000 | |
Gain on sale of containers | $2,000 | ||
Containers | $4,000 | ||
(To record gain on containers not returned by US steel) |
Magnesita has the following transactions related to liabilities in December 2017 and January 2018. Magnesita’s fiscal...
At December 31, 2017, Eastern Manufacturing Corporation had the following selected transactions related to liabilities of the company. The 2017 financial statements are issued March 15, 2018. The company has the following transactions related to liabilities:$12 million borrowed on October 31, 2017 from Second Commercial Bank under a line of credit and issued a 5-month promissory note. Management planned to issued 10-year bonds in February 2018 to repay the note.Received $2,600 of refundable deposits in December for reusable containers used to transport...
Camden Biotechnology began operations in September 2018. The following selected transactions relate to liabilities of the company for September 2018 through March 2019. Camden’s fiscal year ends on December 31. Its financial statements are issued in April. 2018 On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $14,000,000 at the bank’s prime rate (9.5% at the time). The company will pay no commitment fees. On October 1, borrowed $11...
Camden Biotechnology began operations in September 2018. The following selected transactions relate to liabilities of the company for September 2018 through March 2019. Camden’s fiscal year ends on December 31. Its financial statements are issued in April. 2018 On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $17,000,000 at the bank’s prime rate (12.5% at the time). The company will pay no commitment fees. On October 1, borrowed $14...
Camden Biotechnology began operations in September 2018. The following selected transactions relate to liabilities of the company for September 2018 through March 2019, Camden's fiscal year ends on December 31. Its financial statements are issued in April 2018 a. On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $9,000,000 at the bank's prime rate (12.5% at the time b. On October 1, borrowed $6 The company will pay no...
Camden Biotechnology began operations in September 2018. The following selected transactions relate to liabilities of the company for September 2018 through March 2019. Camden’s fiscal year ends on December 31. Its financial statements are issued in April. 2018 On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $14,000,000 at the bank’s prime rate (9.5% at the time). The company will pay no commitment fees. On October 1, borrowed $11...
2
Camden Biotechnology began operations in September 2018. The following selected transactions relate to liabilities of the company for September 2018 through March 2019. Camden's fiscal year ends on December 31. Its financial statements are issued in April. 2018 a. On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $33,000,000 at the bank's prime rate (15.5% at the time). The company will pay no commitment fees. b. On October...
The following selected transactions relate to liabilities of United Insulation Corporation. United’s fiscal year ends on December 31. 2018 Jan. 13 Negotiated a revolving credit agreement with Parish Bank that can be renewed annually upon bank approval. The amount available under the line of credit is $30.0 million at the bank’s prime rate. Feb. 1 Arranged a three-month bank loan of $8.4 million with Parish Bank under the line of credit agreement. Interest at the prime rate of 10% was...
The following selected transactions relate to liabilities of United Insulation Corporation. United’s fiscal year ends on December 31. 2021 Jan. 13 Negotiated a revolving credit agreement with Parish Bank that can be renewed annually upon bank approval. The amount available under the line of credit is $30.0 million at the bank’s prime rate. Feb. 1 Arranged a three-month bank loan of $6.5 million with Parish Bank under the line of credit agreement. Interest at the prime rate of 11% was...
Problem 13-2 Various transactions involving liabilities [LO13-2, 13-3, 13-4] Camden Biotechnology began operations in September 2018. The following selected transactions relate to liabilities of the company for September 2018 through March 2019. Camden's fiscal year ends on December 31. Its financial statements are issued in April. 2018 a. On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $19,000,000 at the bank's prime rate (12.5% at the time). The company...
The following selected transactions relate to liabilities of United Insulation Corporation. United's fiscal year ends on December 31. 2021 Jan. 13 Negotiated a revolving credit agreement with Parish Bank that can be renewed annually upon bank approval. The amount available under the line of credit is $30.0 million at the bank's prime rate. Feb. 1 Arranged a three-month bank loan of $8.4 million with Parish Bank under the line of credit agreement. Interest at the prime rate of 10% was...